Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:2.7.11.1 (protein kinase)
 81,284 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The influence of haloperidol and propranolol on aggressiveness, motility exploration and general behavior, and the activity or level of adenylate cyclase, cyclic AMP, and protein kinase in the brain of mice treated with LSD was tested. Haloperidol evidently, and propranolol slightly less, inhibited the behavioral and biochemical changes induced by LSD. It is suggested that psychotomimetic effects of LSD depend on complex action of this compound on aminergic receptors in the central nervous system, and the antipsychotic effectiveness of haloperidol and propranolol is related to interaction of these drugs and LSD with the receptors for monoamines participating in the central neuromediation.
Pol J Pharmacol Pharm
PMID:The influence of haloperidol and propranolol on behavior and biochemical changes in the brain of mice treated with LSD. 19 69

The cell-free extract from wheat germ contains an inhibitor interfering with translation of a natural template (BMV RNA). The inhibitor affects neither the translation of poly(U) nor the aminoacylation of tRNA. It exhibits the activity of protein kinase (ATP:protein phosphotransferase, EC 2.7.1.37). The inhibitor is found in lipoprotein aggregates which can be separated from ribosomes on Sepharose 2B column. Ribosomes purified on the Sepharose are several times more active in translation of BMV RNA than those isolated by conventional methods.
Acta Biochim Pol 1979
PMID:Isolation of wheat ribosomes free of high molecular weight inhibitors of the natural messenger translation. 50 12

Two yeast casein kinase type-1 species of 45 kDa and 27 kDa (CK1) were purified to apparent homogeneity and used for investigation of their immunological affinity. Antisera against the two kinases were isolated; the antibody against the 45 kDa kinase did not react with the 27 kDa enzyme. The 27 kDa casein kinase was recognized only by its own antibody. The obtained data strongly suggest that the low molecular mass CK-1 is not a proteolytic product of the 45 kDa kinase species.
Acta Biochim Pol 1992
PMID:The 45 kDa and 27 kDa yeast's protein kinases are not immunologically related. 144 47

The activity of EF-2 was distinctly decreased after phosphorylation catalysed by a partly purified calmodulin and Ca2+ dependent protein kinase III. At the same time 32P from [gamma-32P]ATP was incorporated into EF-2 molecule. After dephosphorylation of EF-2 catalysed by alkaline phosphatase the activity of this factor was increased. This suggests that the phosphorylation-dephosphorylation of EF-2 is the regulatory process in the elongation step of the translation. Preliminary purification of the kinase III from rat liver resulted in 8-fold purified enzyme with a recovery of 60%.
Acta Biochim Pol 1991
PMID:The effect of phosphorylation of the EF-2 isolated from rat liver cells on protein biosynthesis in vitro. 166 36

The effect of various dopaminergic agents and related drugs on the activity of the heat-stable inhibitor of cyclic AMP (cAMP)-dependent protein kinase (Walsh inhibitor) and on cAMP accumulation was studied in retinas of light- and dark-adapted rabbits. Both in dark- and light-adapted rabbits low doses of apomorphine increased the retinal Walsh inhibitor activity; high doses of the drug decreased the Walsh inhibitor activity in dark-adapted rabbits, but were without effect in light-adapted animals. S-Sulpiride antagonized the effect of low doses of apomorphine on the Walsh inhibitor activity, and, in contrast to haloperidol (which was effective), did not affect the action of a high apomorphine dose. Selective agonists of dopamine (DA) D2-receptor, quinpirole and bromocriptine, increased the retinal Walsh inhibitor activity in both light- and dark-adapted animals, a selective D1-agonist, SKF 38393, decreased the inhibitor activity in dark- and did not significantly modify it in light-adapted animals. In in vitro experiments, carried out in the presence of theophylline, DA and apomorphine increased cAMP accumulation in pieces of the rabbit retina through activation of D1-receptors. The action of DA, apomorphine, and SKF 38393, was significantly stronger in retinas of dark- than of light-adapted animals. Forskolin stimulated cAMP accumulation in a concentration-dependent manner, producing at 100 microM increases of cAMP levels by approximately 5-fold. DA and SKF 38393 did not significantly modulate the action of 10 microM forskolin, whereas apomorphine slightly decreased the forskolin effect. Of the two selective D2-receptor agonists, bromocriptine slightly decreased, and quinpirole had no effect on the forskolin action. The characteristics of the specific binding of [3H]spiroperidol were essentially the same in the retinas of dark- and light-adapted rabbits. Our data suggest that in light-adapted animals the D1-receptors, or the effector mechanisms for regulation of the Walsh inhibitor activity, may be desensitized. Our results suggest also that in the rabbit retina there are probably no D2-receptors coupled negatively to adenylate cyclase, although a pharmacologically similar class of DA receptors seems to be involved in regulation of the Walsh inhibitor activity (in a way independent on environmental lighting).
Pol J Pharmacol Pharm
PMID:Light modulates dopamine-regulated Walsh inhibitor activity and dopamine-dependent cyclic AMP accumulation in the rabbit retina. 198 30

Studies in the effect of somatostatin and dopamine on the incorporation of 32P from ATP to casein and ribosomes were carried out using purified protein kinase type II, isolated from the human placental cytosol. Low concentrations of somatostatin inhibited, while high ones of dopamine concentrations stimulated the activity of kinase.
Pol J Pharmacol Pharm
PMID:Effect of somatostatin and dopamine on the activity of cyclic AMP-independent protein kinase from human placenta. 289 20

Protein kinase activities are regulated by endogenous thermostable protein inhibitors. Type I inhibitor is a protein of MW 22,000-24,000 which inhibits specifically cyclic AMP-(cAMP) dependent protein kinase (APK) as a competitive inhibitor of catalytic subunits of the enzyme. Type I inhibitor activity changes inversely according to the activation of adenylate cyclase and the changes in cAMP content in tissues. It seems that type I inhibitor serves as a factor preventing spontaneous cAMP-dependent phosphorylation in unstimulated cell. The other thermostable protein which inhibits APK activity has been found in Sertoli cell-enriched testis (testis inhibitor). Physiological role of the testis inhibitor is unknown. Type II inhibitor is a protein of MW 15,000 which blocks phosphorylation mediated by cAMP and cyclic GMP (cGMP) dependent (APK and GPK) and cyclic nucleotide independent protein kinases as a competitive inhibitor of substrate proteins. Activity of this inhibitor specifically changes in reciprocal manner to the changes in cGMP content. It seems that type II inhibitor serves as a factor preventing the phosphorylation catalyzed by GPK when cGMP content is low. Stimulation of guanylate cyclase and activation of GPK is followed by a decrease of type II inhibitor activity. This change in relationship between activities of GPK and type II inhibitor allows for effective phosphorylation catalyzed by this enzyme when cGMP content is increased.
Pol J Pharmacol Pharm
PMID:Regulation of the activity of protein kinases by endogenous heat stable protein inhibitors. 299 38

The protein kinase activity in the postmitochondrial and postribosomal fractions from chick brain at various stages of development was examined. It has been found, that the overall level of protein kinases activity, assayable under the experimental conditions, increases during embryogenesis, sharply decreases at the hatch, and again increases thereafter. The subcellular distribution of protein kinases alters during ontogenetic development. The embryonal protein kinases of both subcellular fractions differ in the protein substrate specificity, cAMP- and salts-sensitivity from those of the adult ones. Thanks to use of ribosomal proteins as an exogenous substrates it was possible to visualize the developmental changes in the protein kinase pattern.
Acta Physiol Pol
PMID:Developmental changes in the protein kinase activity of chick brain. 321 51

Casein kinase type II were isolated by the same procedure, from rat liver, human placenta, Querin carcinoma and yeast, and characterized. The mammalian enzymes were composed of three subunits alpha, alpha' and beta, whereas yeast kinase was composed of two subunits alpha and alpha'. It was shown that the catalytic activity, substrate and phosphate donor specificity, sensitivity to heparin and spermine were the same for all the kinases tested. The results give additional support to the suggestion [1] that the beta subunit is not required for optimal activity and specificity of yeast casein kinase II. The quaternary structure of the yeast enzyme of a molecular weight of approximately 150 000 is proposed as alpha2 alpha'2.
Acta Biochim Pol 1986
PMID:Further studies on the quaternary structure of yeast casein kinase II. 352 Nov 66

Apomorphine produced biphasic changes in the activity of an endogenous, specific inhibitor of cAMP-dependent protein kinase (type I inhibitor). Small doses of apomorphine (50-100 micrograms/kg) induced an increase while high doses (1-10 mg/kg) produced a dose-dependent decrease of the type I inhibitor activity in the striatum of control rats. Prolonged treatment with nomifensin markedly reduced the response of the type I inhibitor both to low and high doses of apomorphine and shifted the dose-response curves to the right. The apomorphine-induced increase of the type I inhibitor activity in nomifensin-pretreated rats was blocked by aminophylline and by small, presynaptically active doses of haloperidol. This suggests that small doses of apomorphine stimulate presynaptic D2 receptor. The apomorphine-induced decrease of the type I inhibitor activity in nomifensin pretreated animals was enhanced by aminophylline and by presynaptically active dose of haloperidol. In contrast, this action of apomorphine was blocked by high, postsynaptically active, dose of haloperidol. It suggested postsynaptic site of action of high doses of apomorphine. Prolonged pretreatment with nomifensin resulted in subsensitivity of both presynaptic D2 and postsynaptic D1 receptors.
Pol J Pharmacol Pharm
PMID:The responsiveness of the endogenous inhibitor of cAMP-dependent protein kinase to apomorphine in rat striatum after prolonged treatment with nomifensin. 407 79


1 2 3 4 5 6 7 8 9 10 Next >>